No abstract available
Publication types
-
Case Reports
-
Comparative Study
-
Review
MeSH terms
-
Adrenergic alpha-Antagonists / therapeutic use
-
Age Factors
-
Aged
-
Angiotensin-Converting Enzyme Inhibitors / administration & dosage
-
Angiotensin-Converting Enzyme Inhibitors / therapeutic use
-
Antihypertensive Agents / administration & dosage
-
Antihypertensive Agents / therapeutic use
-
Calcium Channel Blockers / administration & dosage
-
Calcium Channel Blockers / therapeutic use
-
Coronary Disease / complications
-
Death, Sudden, Cardiac / prevention & control
-
Diabetes Complications
-
Diuretics / administration & dosage
-
Diuretics / therapeutic use
-
Drug Therapy, Combination
-
Female
-
Follow-Up Studies
-
Heart Failure / prevention & control
-
Humans
-
Hypertension / complications
-
Hypertension / diagnosis
-
Hypertension / drug therapy
-
Hypertension / mortality
-
Hypertension / therapy*
-
Male
-
Meta-Analysis as Topic
-
Middle Aged
-
Myocardial Infarction / prevention & control
-
Patient Education as Topic
-
Placebos
-
Randomized Controlled Trials as Topic
-
Risk
-
Risk Factors
-
Stroke / prevention & control
-
Time Factors
-
World Health Organization
Substances
-
Adrenergic alpha-Antagonists
-
Angiotensin-Converting Enzyme Inhibitors
-
Antihypertensive Agents
-
Calcium Channel Blockers
-
Diuretics
-
Placebos